328.79
BATS BZX Real-Time Price
As of 1:36pm ET
 -9.44 / -2.79%
Today’s Change
249.17
Today|||52-Week Range
388.67
+3.21%
Year-to-Date

Today’s Trading

Previous close338.23
Today’s open337.12
Day’s range327.98 - 337.12
Volume30,051
Average volume (3 months)1,546,332
Market cap$68.1B
Data as of 1:36pm ET, 10/18/2018

Growth & Valuation

Earnings growth (last year)-29.56%
Earnings growth (this year)+15.95%
Earnings growth (next 5 years)+7.20%
Revenue growth (last year)+7.81%
P/E ratio23.3
Price/Sales6.17
Price/Book5.67

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-9.33-2.84%
GILDGilead Sciences-2.06-2.72%
TLRYTilray Inc+0.94+0.63%
NBIXNeurocrine Bioscienc...-1.24-1.08%
Data as of 1:37pm ET, 10/18/2018

Financials

Next reporting dateOctober 23, 2018
EPS forecast (this quarter)$6.77
Annual revenue (last year)$11.0B
Annual profit (last year)$2.5B
Net profit margin23.10%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Jeffrey D. Capello
Corporate headquarters
Cambridge, Massachusetts

Forecasts